Véronique Dalstein

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2024
HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies.

Emma Loeffler, Julien Ancel, Véronique Dalstein

|Jul 24, 2021
Hypoxia in Lung Cancer Management: A Translational Approach.

Julien Ancel, Jeanne-Marie Perotin, Maxime Dewolf

|Jun 23, 2020
Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns.

Sylvie Brassart-Pasco, Véronique Dalstein, Bertrand Brassart

|Sep 25, 2019
Programmed Death-Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC.

Julien Ancel, Philippe Birembaut, Maxime Dewolf

Pageof 1